Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study

Background Results of studies investigating the association between body mass index (BMI) and mortality in patients with coronavirus disease-2019 (COVID-19) have been conflicting. Methods This multicenter, retrospective observational study, conducted between January 2020 and August 2021, evaluated t...

Full description

Bibliographic Details
Main Authors: Jeongsu Kim, Jin Ho Jang, Kipoong Kim, Sunghoon Park, Su Hwan Lee, Onyu Park, Tae Hwa Kim, Hye Ju yeo, Woo Hyun Cho
Format: Article
Language:English
Published: The Korean Academy of Tuberculosis and Respiratory Diseases 2024-04-01
Series:Tuberculosis and Respiratory Diseases
Subjects:
Online Access:http://e-trd.org/upload/pdf/trd-2023-0126.pdf
_version_ 1827300328060485632
author Jeongsu Kim
Jin Ho Jang
Kipoong Kim
Sunghoon Park
Su Hwan Lee
Onyu Park
Tae Hwa Kim
Hye Ju yeo
Woo Hyun Cho
author_facet Jeongsu Kim
Jin Ho Jang
Kipoong Kim
Sunghoon Park
Su Hwan Lee
Onyu Park
Tae Hwa Kim
Hye Ju yeo
Woo Hyun Cho
author_sort Jeongsu Kim
collection DOAJ
description Background Results of studies investigating the association between body mass index (BMI) and mortality in patients with coronavirus disease-2019 (COVID-19) have been conflicting. Methods This multicenter, retrospective observational study, conducted between January 2020 and August 2021, evaluated the impact of obesity on outcomes in patients with severe COVID-19 in a Korean national cohort. A total of 1,114 patients were enrolled from 22 tertiary referral hospitals or university-affiliated hospitals, of whom 1,099 were included in the analysis, excluding 15 with unavailable height and weight information. The effect(s) of BMI on patients with severe COVID-19 were analyzed. Results According to the World Health Organization BMI classification, 59 patients were underweight, 541 were normal, 389 were overweight, and 110 were obese. The overall 28-day mortality rate was 15.3%, and there was no significant difference according to BMI. Univariate Cox analysis revealed that BMI was associated with 28-day mortality (hazard ratio, 0.96; p=0.045), but not in the multivariate analysis. Additionally, patients were divided into two groups based on BMI ≥25 kg/m2 and underwent propensity score matching analysis, in which the two groups exhibited no significant difference in mortality at 28 days. The median (interquartile range) clinical frailty scale score at discharge was higher in nonobese patients (3 [3 to 5] vs. 4 [3 to 6], p<0.001). The proportion of frail patients at discharge was significantly higher in the nonobese group (28.1% vs. 46.8%, p<0.001). Conclusion The obesity paradox was not evident in this cohort of patients with severe COVID-19. However, functional outcomes at discharge were better in the obese group.
first_indexed 2024-04-24T16:01:42Z
format Article
id doaj.art-707582ec06c94113aa5fc1a47840e614
institution Directory Open Access Journal
issn 1738-3536
2005-6184
language English
last_indexed 2024-04-24T16:01:42Z
publishDate 2024-04-01
publisher The Korean Academy of Tuberculosis and Respiratory Diseases
record_format Article
series Tuberculosis and Respiratory Diseases
spelling doaj.art-707582ec06c94113aa5fc1a47840e6142024-04-01T07:30:27ZengThe Korean Academy of Tuberculosis and Respiratory DiseasesTuberculosis and Respiratory Diseases1738-35362005-61842024-04-0187217618410.4046/trd.2023.01264851Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter StudyJeongsu Kim0Jin Ho Jang1Kipoong Kim2Sunghoon Park3Su Hwan Lee4Onyu Park5Tae Hwa Kim6Hye Ju yeo7Woo Hyun Cho8 Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea Division of Cardiology, Department of Internal Medicine, Yonsei University Health System, Seoul, Republic of Korea Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of KoreaBackground Results of studies investigating the association between body mass index (BMI) and mortality in patients with coronavirus disease-2019 (COVID-19) have been conflicting. Methods This multicenter, retrospective observational study, conducted between January 2020 and August 2021, evaluated the impact of obesity on outcomes in patients with severe COVID-19 in a Korean national cohort. A total of 1,114 patients were enrolled from 22 tertiary referral hospitals or university-affiliated hospitals, of whom 1,099 were included in the analysis, excluding 15 with unavailable height and weight information. The effect(s) of BMI on patients with severe COVID-19 were analyzed. Results According to the World Health Organization BMI classification, 59 patients were underweight, 541 were normal, 389 were overweight, and 110 were obese. The overall 28-day mortality rate was 15.3%, and there was no significant difference according to BMI. Univariate Cox analysis revealed that BMI was associated with 28-day mortality (hazard ratio, 0.96; p=0.045), but not in the multivariate analysis. Additionally, patients were divided into two groups based on BMI ≥25 kg/m2 and underwent propensity score matching analysis, in which the two groups exhibited no significant difference in mortality at 28 days. The median (interquartile range) clinical frailty scale score at discharge was higher in nonobese patients (3 [3 to 5] vs. 4 [3 to 6], p<0.001). The proportion of frail patients at discharge was significantly higher in the nonobese group (28.1% vs. 46.8%, p<0.001). Conclusion The obesity paradox was not evident in this cohort of patients with severe COVID-19. However, functional outcomes at discharge were better in the obese group.http://e-trd.org/upload/pdf/trd-2023-0126.pdfbody mass indexcovid-19mortality
spellingShingle Jeongsu Kim
Jin Ho Jang
Kipoong Kim
Sunghoon Park
Su Hwan Lee
Onyu Park
Tae Hwa Kim
Hye Ju yeo
Woo Hyun Cho
Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study
Tuberculosis and Respiratory Diseases
body mass index
covid-19
mortality
title Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study
title_full Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study
title_fullStr Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study
title_full_unstemmed Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study
title_short Functional Aspects of the Obesity Paradox in Patients with Severe Coronavirus Disease-2019: A Retrospective, Multicenter Study
title_sort functional aspects of the obesity paradox in patients with severe coronavirus disease 2019 a retrospective multicenter study
topic body mass index
covid-19
mortality
url http://e-trd.org/upload/pdf/trd-2023-0126.pdf
work_keys_str_mv AT jeongsukim functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy
AT jinhojang functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy
AT kipoongkim functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy
AT sunghoonpark functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy
AT suhwanlee functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy
AT onyupark functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy
AT taehwakim functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy
AT hyejuyeo functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy
AT woohyuncho functionalaspectsoftheobesityparadoxinpatientswithseverecoronavirusdisease2019aretrospectivemulticenterstudy